Healthcare insurance company Molina Healthcare (NYSE:MOH) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.3% year on year to $11.38 billion. On the other hand, the company’s full-year revenue guidance of $44.5 billion at the midpoint came in 4.9% below analysts’ estimates. Its non-GAAP loss of $2.75 per share was significantly below analysts’ consensus estimates.
Shares of healthcare insurance company Molina Healthcare (NYSE:MOH)
fell 7.3% in the afternoon session after the U.S. government proposed a significantly smaller-than-expected increase in payments for private Medicare Advantage plans for 2027.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
CMS said that the proposed policies are projected to result in a net average year-over-year payment increase of 0.09% for Medicare Advantage plans in CY 2027.
As the morning bell rang on Wall Street this Thursday, January 22, 2026, the Department of Labor released a set of figures that have sent economists back to their spreadsheets. Initial jobless claims for the week ending January 17 rose slightly to 200,000, up from a revised 199,000
Date: January 2, 2026 The healthcare sector began the 2026 trading year with a renewed sense of optimism, and among the early movers was Molina Healthcare (NYSE: MOH). Shares of the Long Beach-based managed care giant rose 1.69% in early trading today, reflecting a broader rotation into value-oriented healthcare stocks after a period of intense [...]
Exciting developments are taking place for the stocks in this article.
They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
As the clock ticks toward the final closing bell of 2025, the financial markets are witnessing a familiar, if somewhat somber, ritual. Despite a year that saw the S&P 500 climb nearly 17.3%, today’s session is marked by the "Final Trading Day" phenomenon—a period of low-volume
